Asia Pacific Biosurgery Market – Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Sep 2019
  • Asia-Pacific
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

Asia Pacific Biosurgery Market By Product (Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants & Adhesives, Adhesion Barriers, Staple-Line Reinforcement Agents), Application (General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery, Reconstructive Surgery, Gynecological Surgery, Thoracic Surgery, Urological Surgery), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific ) – Industry Trends and Forecast to 2026

Market Analysis: Asia-Pacific Biosurgery Market

Asia-Pacific biosurgery market is registering a healthy CAGR of 10.05% in the forecast period of 2019-2026. The rise in the market can be attributed due to the surge in the elderly population which is contributing to the growth of the market.

Market Definition: Asia-Pacific Biosurgery Market

The surge in the elderly population is raising the rate of surgeries being performed. Biosurgery has become the most preferred surgery as it has less intra and post complications. It is a type of surgical method that involves the usage of various natural and synthetically produced surgical products. These products are used to isolate the wound and prevent the blood loss by soaking the fluids and sealing the wound. Implementation of these products helps in complications associated with surgeries and helps in reducing the time required post-treatment.

Market Drivers

  • Rising elderly population is driving the market growth
  • Increasing demand for innovative product developments and launches for the management of blood loss in patients undergoing surgical procedures is boosting the market growth
  • The various advantages of biosurgeries over the traditional surgical methods is driving the market growth
  • Surge in the joint reconstruction and spinal fusion is fueling the market growth

Market Restraints

  • The rise in the cost of the surgical procedures is hindering the market growth
  • The stringent regulatory approval process sis hampering the market growth
  • The various complications associated with orthopedic surgery  is hindering the market growth

Segmentation: Asia-Pacific Biosurgery Market

By Product

  • Bone-Graft Substitutes

    • Demineralized Bone Matrix
    • Synthetic Bone Grafts
    • Bone Morphogenetic Proteins
    • Others

  • Soft-Tissue Attachments

    • Synthetic Meshes
    • Biological Meshes

      • Allografts
      • Xenografts

  • Hemostatic Agents

    • Thrombin-Based Hemostatic Agents
    • Oxidized Regenerated Cellulose-Based Hemostatic Agents
    • Combination Hemostatic Agents

  • Surgical Sealants & Adhesives

    • Natural/Biological Sealants & Adhesives

      • Fibrin Sealants
      • Collagen-Based Sealants
      • Gelatin-Based Sealants
      • Albumin-Based Sealants
      • Others

    • Natural/Biological Sealants & Adhesives

      • Human Blood-Based Sealants & Adhesives
      • Animal-Based Sealants & Adhesives

    • Synthetic & Semi-Synthetic Sealants & Adhesives

      • Peg Hydrogels
      • Cyanoacrylate-Based Sealants & Adhesives
      • Urethane-Based Sealants & Adhesives
      • Others

  • Adhesion Barriers

    • Synthetic Adhesion Barriers

      • Hyaluronic Acid-Based Adhesion Barriers
      • Regenerated Cellulose-Based Adhesion Barriers
      • Peg-Based Adhesion Barriers
      • Ther Synthetic Adhesion Barriers

    • Natural Adhesion Barriers

      • Collagen & Protein Adhesion Barriers
      • Fibrin-Based Adhesion Barriers

  • Staple-Line Reinforcement Agents

By Application

  • General Surgery
  • Cardiovascular Surgery
  • Orthopedic Surgery
  • Neurological Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Thoracic Surgery
  • Urological Surgery

By Country

  • Japan
  • China
  • South Korea
  • India
  • Australia
  • Singapore
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Rest of APAC

Key Developments in the Market:

  • In June 2019, Johnson & Johnson Services Inc. had successfully cleared the FDA clearance for its airless spray devices which will facilitate to deliver Grifols, a sealant used for stopping bleeding at the time of surgery. The launch had advanced the offering of the company in the biosurgery field.
  • In October 2018, Getinge AB has announced that it will sell its biosurgery business division to the SeCQure Surgical as it will complete the production and offerings of the SeCQure Surgical. The company deals into minimally invasive procedures, staplers and mesh.

Competitive Analysis:

Asia-Pacific biosurgery market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of biosurgery market for Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.

Key Market Competitors:

Few of the major market competitors currently working in the Asia-Pacific biosurgery market are Medtronic, Stryker, Johnson & Johnson Services Inc., Baxter, BD, Aroa Biosurgery Limited, CryoLife Inc., Sanofi, CSL Limited, Integra LifeSciences Corporation, Pfizer Inc., B. Braun Melsungen AG, Cardinal Health, Tissue Regenix and Getinge AB among others.

Research Methodology:  Asia-Pacific Biosurgery Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of Asia-Pacific biosurgery market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19